Acute Respiratory Distress Syndrome Market

1
ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)

• MARKET INSIGHTS, EPIDEMIOLOGYMARKET
  FORECAST-2027

2
ACUTE RESPIRATORY DISTRESS SYNDROME

• Acute Respiratory Distress Syndrome (ARDS) is a
  life- threatening severe orphan disease in which
  the air sacs present in alveoli are filled with
  fluid and lower the amount of oxygen in blood.
  Thus, enough oxygen is not supplied to the body.
  Inflammation may occur throughout the lungs.
• ARDS is also classified on the basis of severity
  of disease as Mild ARDS, Moderate ARDS and Severe
  ARDS by Berlin definition. It is generally
  characterized into three stages such as exudative
  stage, fibro proliferative (or proliferative)
  stage, resolution and recovery stage.

• DelveInsight 2018 All rights reserved

3
EPIDEMIOLOGY INSIGHTS
Cross-sectional studies demonstrate that patients
with ARDS represent approximately 5 of
hospitalized, mechanically ventilated patients.
ARDS occurrence varies consistently, ranging from
10.6 per 100,000 person-years in Finland, to 17.9
per 100,000 person-years in Scandinavia, to 25.5
per 100,000 person-years in Spain.
1
3
2
4
DelveInsight estimates ARDS incidence has varied
from 1.3 to 22 per 100,000 person years.
Mild ARDS represents only 25 of patients with
ARDS, approximately 75 of patients are reported
with moderate or severe ARDS.

• DelveInsight 2018 All rights reserved

4
4
MARKET INSIGHTS
Extensive research and development activities of
pharmaceutical companies are being carried out
for developing the therapies for ARDS along with
the emerging therapies in the pipeline
Expected launch of BioMark Pharmaceuticals
BIO-11006, Techpool, Bio-Pharmas Ulinastatin and
other therapies shall impact the market size of
ARDS
ARDS
Owing to the launch of upcoming therapies, the
market size shall increase significantly during
forecast period (2018-2027)
There are many potential pipeline drugs expected
to enter ARDS market by XXXX and subsequent years.
Market Size of ARDS in the 7MM was found to be
XXX in 2016

• DelveInsight 2018 All rights reserved

5
5
KEY PLAYERS
01
BioMarck Pharmaceuticals
02
Techpool Bio-Pharma
03
Faron Pharmaceuticals

• DelveInsight 2018 All rights reserved

6
COMPLETE INFORMATION
For complete information please click below
Or Write to us at info_at_delveinsight.com
CLICK HERE

• DelveInsight 2018 All rights reserved

7
7
ABOUT DELVEINSIGHT
DelveInsight, market research and consulting
firm, provides end to end comprehensive solutions
to the Life Science Industry. We help our
customers in best decision making through our
expertise in research analysis and comes out
with unmatched data forecasts
Vision Insight across the value chain to
help organizations make important business
decisions through the use and analysis of
actionable market intelligence

• Mission
• To be the most trusted marketing research firm
  business consulting firm worldwide.
• To be a renowned and premier data driven solution
  providers among Pharma Biotech companies.

01
02
03

• DelveInsight 2018 All rights reserved

8
SERVICE OFFERINGS AT DELVEINSIGHT
Comprehensive solution for strategic business
decisions

• Market Size
• Market Dynamics
• Market Assessment

MarketIntelligence

• Drug Sales Forecast
• Indication Forecast
• Late Stage Pipeline Analysis

Forecasting

• Asset Prioritization
• Brand Optimization
• Portfolio Expansion

• Competitive landscape
• Clinical Trials
• Therapeutic Assessment

• Opportunity Assessment for
• Licensing
• Market Access
• Partnership

• Primary Analytics
• News-Letters
• Conference Tracking
• Clinical Trials Tracking

• Access over 3000 Reports
• API
• Market Pipeline
• Indication Epidemiology

• Trends Analysis
• Physicians Patients Perception
• KOLs

• DelveInsight 2018 All rights reserved

9
Add a Slide Title - 5
Contact Us info_at_delveinsight.com 91-11-4568
9769 www.delveinsight.com blog/delveInsight/ tw
itter/delveInsight LinkedIn/delveInsight